• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number PB 10
Device Problems Gradient Increase (1270); Perivalvular Leak (1457); Device Dislodged or Dislocated (2923)
Patient Problems Mitral Regurgitation (1964); Thrombus (2101); Cardiac Perforation (2513)
Event Date 08/29/2017
Event Type  Injury  
Manufacturer Narrative
Citation: yoon, sh.Md.Et al.Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty ringsj.Joutnal of the american college of cardiology.(2017) vol.70, no.9 doi 10.1016/j.Jacc.2017.07.714 earliest date of e-publish/publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information, it cannot be determined whether this event has been previously reported.(b)(4).
 
Event Description
Medtronic received information via literature review regarding outcomes after a transcatheter mitral valve replacement (tmvr).All data were collected from a multi-center, multi-national registry between 2009 and 2017.The study population included 248 patients, all of which had a previously implant mitral annuloplasty ring, band or mitral bioprosthetic valve.Four patients were implanted valve-in-valve with a melody transcatheter bioprosthetic valve.Serial numbers were not provided.The study population was predominantly female; mean age 72.5 years.Among all patients adverse events included: conversion to surgery, left ventricular outflow tract (lvot) obstruction, valve dislodgement, the implant of a second valve, left ventricle perforation, thrombus, increased gradient measurements, and greater than moderate mitral regurgitation.Other adverse events included; reintervention due to paravalvular leak (pvl), atrial septal defect or surgical mitral replacement.Based on the available information, these events may have been attributed to a medtronic product.However as multiple manufacturers were noted in the literature, a direct correlation could not be made between the observed adverse events and the medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELODY TRANSCATHETER PULMONARY VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7133954
MDR Text Key95373658
Report Number2025587-2017-02505
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPB 10
Device Catalogue NumberPB 10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/22/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-